Advertisement

Supportive Care in Cancer

, Volume 26, Issue 10, pp 3517–3526 | Cite as

Cancer cost communication: experiences and preferences of patients, caregivers, and oncologists—a nationwide triad study

  • So Young Kim
  • Dong Wook Shin
  • Boyoung Park
  • Juhee Cho
  • Jae Hwan Oh
  • Sun Seog Kweon
  • Hye Sook Han
  • Hyung Kook Yang
  • Keeho Park
  • Jong-Hyock ParkEmail author
Original Article

Abstract

Purpose

We assessed cost communication between cancer patients, caregivers, and oncologists and identified factors associated with communication concordance.

Methods

A national, multicenter, cross-sectional survey of patient-caregiver-oncologist triads was performed, and 725 patient-caregiver pairs, recruited by 134 oncologists in 13 cancer centers, were studied. Discordance in preferences and experiences regarding cost communication between patients, caregivers, and oncologists were assessed. Hierarchical generalized linear models were used to identify predictors of concordance and to identity the possible association of concordance with patient satisfaction and degree of trust in the physician.

Results

Although the oncologists thought that patients would be affected by the cost of care, only half of them were aware of the subjective burden experienced by their patients, and the degree of concordance for this parameter was very low (weighted kappa coefficient = 0.06). Caregivers consistently showed similar preferences to those of the patients. After controlling for covariates, the education level of patients [adjusted odds ratio (aOR) for > 12 vs. < 9 years, 2.92; 95% confidence interval (CI), 1.87–4.56], actual out-of-pocket costs [aOR for ≥ 8 million vs. < 2 million Korean Won, 0.56; 95% CI, 0.34–0.89], and physician age (aOR for ≥ 55 vs. < 45 years, 1.83; 95% CI, 1.04–3.21) were significant.

Conclusions

The results show underestimation by oncologists regarding the subjective financial burden on a patient, and poor patient-physician concordance in cost communication. Oncologists should be more cognizant of patient OOP costs that are not indexed by objective criteria, but instead involve individual patient perceptions.

Keywords

Out-of-pocket costs Patient-physician communication Concordance 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Supplementary material

520_2018_4201_MOESM1_ESM.docx (22 kb)
Table A1 (DOCX 22 kb)

References

  1. 1.
    Nekhlyudov L, Levit L, Hurria A, Ganz PA (2014) Patient-centered, evidence-based, and cost-conscious cancer care across the continuum: translating the Institute of Medicine report into clinical practice. CA Cancer J Clin 64(6):408–421.  https://doi.org/10.3322/caac.21249 CrossRefPubMedGoogle Scholar
  2. 2.
    Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, Khayat D, Boyle P, Autier P, Tannock IF, Fojo T, Siderov J, Williamson S, Camporesi S, McVie JG, Purushotham AD, Naredi P, Eggermont A, Brennan MF, Steinberg ML, De Ridder M, McCloskey SA, Verellen D, Roberts T, Storme G, Hicks RJ, Ell PJ, Hirsch BR, Carbone DP, Schulman KA, Catchpole P, Taylor D, Geissler J, Brinker NG, Meltzer D, Kerr D, Aapro M (2011) Delivering affordable cancer care in high-income countries. Lancet Oncol 12(10):933–980.  https://doi.org/10.1016/s1470-2045(11)70141-3 CrossRefPubMedGoogle Scholar
  3. 3.
    Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, Ubel PA, Schnipper LE, American Society of Clinical O (2009) American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 27(23):3868–3874.  https://doi.org/10.1200/JCO.2009.23.1183 CrossRefPubMedGoogle Scholar
  4. 4.
    Kim SY, Park J-H, Kang KH, Hwang I, Yang HK, Won Y-J, Seo H-G, Lee D, Yoon S-J (2014) The economic burden of cancer in Korea in 2009. Asian Pacif J Cancer Prevent: APJCP 16(3):1295–1301CrossRefGoogle Scholar
  5. 5.
    Dusetzina SB, Basch E, Keating NL (2015) For uninsured cancer patients, outpatient charges can be costly, putting treatments out of reach. Health Aff 34(4):584–591CrossRefGoogle Scholar
  6. 6.
    Kuehn BM (2014) Guidelines, online training aim to teach physicians to weigh costs of care, become better stewards of medical resources. JAMA 311(23):2368–2370CrossRefPubMedGoogle Scholar
  7. 7.
    Bernard DS, Farr SL, Fang Z (2011) National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol 29(20):2821–2826.  https://doi.org/10.1200/JCO.2010.33.0522 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Ramsey SD, Bansal A, Fedorenko CR, Blough DK, Overstreet KA, Shankaran V, Newcomb P (2016) Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol 34(9):980–986CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Perrone F, Jommi C, Di Maio M, Gimigliano A, Gridelli C, Pignata S, Ciardiello F, Nuzzo F, de Matteis A, Del Mastro L, Bryce J, Daniele G, Morabito A, Piccirillo MC, Rocco G, Guizzaro L, Gallo C (2016) The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy. Ann Oncol 27(12):2224–2229.  https://doi.org/10.1093/annonc/mdw433 CrossRefPubMedGoogle Scholar
  10. 10.
    Huntington SF (2016) Cancer-related financial toxicity: beyond the realm of drug pricing and out-of-pocket costs. Ann Oncol 27(12):2143–2145.  https://doi.org/10.1093/annonc/mdw540 CrossRefPubMedGoogle Scholar
  11. 11.
    Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D (2015) Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study. J Oncol Pract 11(2):145–150CrossRefPubMedGoogle Scholar
  12. 12.
    Zafar SY, Abernethy AP (2013) Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park, NY) 27(2):80Google Scholar
  13. 13.
    Weaver KE, Rowland JH, Bellizzi KM, Aziz NM (2010) Forgoing medical care because of cost. Cancer 116(14):3493–3504CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Blumenthal-Barby JS, Robinson E, Cantor SB, Naik AD, Russell HV, Volk RJ (2015) The neglected topic: presentation of cost information in patient decision AIDS. Med Decis Mak 35(4):412–418.  https://doi.org/10.1177/0272989X14564433 CrossRefGoogle Scholar
  15. 15.
    Bullock AJ, Hofstatter EW, Yushak ML, Buss MK (2012) Understanding patients’ attitudes toward communication about the cost of cancer care. J Oncol Pract 8(4):e50–e58CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Tseng C-W, Waitzfelder BE, Tierney EF, Gerzoff RB, Marrero DG, Piette JD, Karter AJ, Curb JD, Chung R, Mangione CM (2010) Patients’ willingness to discuss trade-offs to lower their out-of-pocket drug costs. Arch Intern Med 170(16):1502–1504PubMedPubMedCentralGoogle Scholar
  17. 17.
    Shih YT, Chien CR (2016) A review of cost communication in oncology: patient attitude, provider acceptance, and outcome assessment. Cancer 123:928–939.  https://doi.org/10.1002/cncr.30423 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Hunter WG, Zhang CZ, Hesson A, Davis JK, Kirby C, Williamson LD, Barnett JA, Ubel PA (2016) What strategies do physicians and patients discuss to reduce out-of-pocket costs? Analysis of cost-saving strategies in 1,755 outpatient clinic visits. Med Decis Mak 36(7):900–910.  https://doi.org/10.1177/0272989X15626384 CrossRefGoogle Scholar
  19. 19.
    Henrikson NB, Tuzzio L, Loggers ET, Miyoshi J, Buist DS (2014) Patient and oncologist discussions about cancer care costs. Support Care Cancer 22(4):961–967.  https://doi.org/10.1007/s00520-013-2050-x CrossRefPubMedGoogle Scholar
  20. 20.
    Hunter WG, Hesson A, Davis JK, Kirby C, Williamson LD, Barnett JA, Ubel PA (2016) Patient-physician discussions about costs: definitions and impact on cost conversation incidence estimates. BMC Health Serv Res 16:108.  https://doi.org/10.1186/s12913-016-1353-2 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Kelly RJ, Forde PM, Elnahal SM, Forastiere AA, Rosner GL, Smith TJ (2015) Patients and physicians can discuss costs of cancer treatment in the clinic. J Oncol Pract 11(4):308–312CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Irwin B, Kimmick G, Altomare I, Marcom PK, Houck K, Zafar SY, Peppercorn J (2014) Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist 19(11):1135–1140CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Tarn DM, Paterniti DA, Heritage J, Hays RD, Kravitz RL, Wenger NS (2006) Physician communication about the cost and acquisition of newly prescribed medications. Am J Manag Care 12(11):657–664PubMedGoogle Scholar
  24. 24.
    Kaser E, Shaw J, Marven M, Swinburne L, Boyle F (2010) Communication about high-cost drugs in oncology—the patient view. Ann Oncol 21(9):1910–1914.  https://doi.org/10.1093/annonc/mdq068 CrossRefPubMedGoogle Scholar
  25. 25.
    Altomare I, Irwin B, Zafar SY, Houck K, Maloney B, Greenup R, Peppercorn J (2016) Physician experience and attitudes toward addressing the cost of cancer care. J Oncol Pract 12(3):e281–e288, 247-288.  https://doi.org/10.1200/JOP.2015.007401 CrossRefPubMedGoogle Scholar
  26. 26.
    Riggs KR, Ubel PA (2014) Overcoming barriers to discussing out-of-pocket costs with patients. JAMA Intern Med 174(6):849–850.  https://doi.org/10.1001/jamainternmed.2014.853 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Schrag D, Hanger M (2007) Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey. J Clin Oncol 25(2):233–237.  https://doi.org/10.1200/JCO.2006.09.2437 CrossRefPubMedGoogle Scholar
  28. 28.
    Alexander GC, Casalino LP, Meltzer DO (2003) Patient-physician communication about out-of-pocket costs. JAMA 290(7):953–958CrossRefPubMedGoogle Scholar
  29. 29.
    Janz NK, Wren PA, Copeland LA, Lowery JC, Goldfarb SL, Wilkins EG (2004) Patient-physician concordance: preferences, perceptions, and factors influencing the breast cancer surgical decision. J Clin Oncol 22(15):3091–3098CrossRefPubMedGoogle Scholar
  30. 30.
    Degner LF, Kristjanson LJ, Bowman D, Sloan JA, Carriere K, O'neil J, Bilodeau B, Watson P, Mueller B (1997) Information needs and decisional preferences in women with breast cancer. JAMA 277(18):1485–1492CrossRefPubMedGoogle Scholar
  31. 31.
    Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMedGoogle Scholar
  32. 32.
    Neumann PJ, Palmer JA, Nadler E, Fang C, Ubel P (2010) Cancer therapy costs influence treatment: a national survey of oncologists. Health Aff (Millwood) 29(1):196–202.  https://doi.org/10.1377/hlthaff.2009.0077 CrossRefGoogle Scholar
  33. 33.
    Medicine) II (2014) Partnering with patients to drive shared decisions, better value, and care improvement. The National Academies Press, Washington, DCGoogle Scholar
  34. 34.
    Shay LA, Lafata JE (2015) Where is the evidence? A systematic review of shared decision making and patient outcomes. Med Decis Mak 35(1):114–131.  https://doi.org/10.1177/0272989X14551638 CrossRefGoogle Scholar
  35. 35.
    Berry SR, Bell CM, Ubel PA, Evans WK, Nadler E, Strevel EL, Neumann PJ (2010) Continental divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs. J Clin Oncol 28(27):4149–4153.  https://doi.org/10.1200/JCO.2010.29.1625 CrossRefPubMedGoogle Scholar
  36. 36.
    Ubel PA, Abernethy AP, Zafar SY (2013) Full disclosure—out-of-pocket costs as side effects. N Engl J Med 369(16):1484–1486CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.College of Medicine, Graduate School of Health Science Business ConvergenceChungbuk National UniversityCheongjuRepublic of Korea
  2. 2.Chungbuk National University HospitalCheongjuRepublic of Korea
  3. 3.Department of Family Medicine/Supportive Care CenterSamsung Medical CenterSeoulRepublic of Korea
  4. 4.Department of Medicine, College of MedicineHanyang UniversitySeoulRepublic of Korea
  5. 5.National Cancer Control InstituteNational Cancer CenterGoyangRepublic of Korea
  6. 6.Department of Health, Behavior, and SocietyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  7. 7.Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and TechnologySungkyunkwan UniversitySeoulRepublic of Korea
  8. 8.Center for Colorectal CancerNational Cancer CenterGoyangRepublic of Korea
  9. 9.Department of Preventive MedicineChonnam National University Medical SchoolGwangjuRepublic of Korea

Personalised recommendations